Preterm infants at disproportionately high risk from RSV 26 Feb 2024 4 min read verified RSVResearch summary
Five key factors that allowed COVAX to deliver two billion COVID-19 vaccines 15 Feb 2024 7 min read verified COVAXCOVID-19
Lessons from Lower-Income Countries’ COVID-19 Vaccination Efforts 23 Jan 2024 5 min read verified Cross-postsCOVAXCOVID-19
Leading on vaccine equity: reflections on 100 days as interim CEO 14 Nov 2023 4 min read verified Routine immunisationCOVAX
RSV vaccines: Are we close to taming one of the world’s biggest killers of children? 24 May 2023 4 min read verified RSVVaccine development
Three countries that have seen the impact of COVID-19 vaccine delivery funding 1 May 2023 3 min read verified COVID-19COVAX
COVID-19 vaccine coverage continues to increase in lower-income countries 19 Apr 2023 2 min read verified COVID-19COVAX
Snow-capped peaks and ice-lined refrigerators: extending the cold chain far into Nepal’s Himalayas 20 Mar 2023 6 min read verified COVID-19COVAX
Why does it feel like everyone is sick at the moment? 27 Feb 2023 8 min read verified COVID-19RSVInfluenza
Which lower-income countries saw the biggest COVID-19 vaccination coverage gains in 2022? 15 Feb 2023 5 min read verified COVID-19COVAX
A “tripledemic” of viruses is fuelling a surge in pneumonia, but what are the symptoms to look out for? 19 Jan 2023 4 min read verified PneumoniaCOVID-19RSV
How Botswana, a self-financing COVAX country, solved its pandemic strategy puzzle 11 Jan 2023 7 min read verified COVAXVaccine campaigns
How do RSV symptoms differ from flu, COVID-19 and other respiratory viruses? 21 Dec 2022 4 min read verified RSVExplainerOutbreaksVideos
COVID, flu, RSV – how this triple threat of respiratory viruses could collide this winter 22 Nov 2022 5 min read verified Cross-postsCOVID-19InfluenzaRSV
How scientists are closing in RSV, a silent killer of babies worldwide 15 Nov 2022 6 min read verified RSVVaccine development